# Orphan receptor GPR153 facilitates vascular damage responses by modulating cAMP levels, YAP/TAZ signaling, and NF-κB activation

**Authors:** Jingchen Shao, Jeonghyeon Kwon, Tianpeng Wang, Stefan Günther, Lukas S. Tombor, Timothy Warwick, Zaib Shaheryar, Ralf P. Brandes, Stefanie Dimmeler, Jan Wenzel, Stefan Offermanns, Markus Schwaninger, Nina Wettschureck

PMC · DOI: 10.1038/s41467-025-61057-w · Nature Communications · 2025-07-07

## TL;DR

The orphan receptor GPR153 promotes vascular damage responses by controlling cell signaling and inflammation, and its absence protects against vascular diseases.

## Contribution

This study identifies GPR153 as a novel modulator of vascular inflammation and proliferation through cAMP regulation and YAP/TAZ/NF-κB signaling.

## Key findings

- GPR153 deficiency reduces smooth muscle cell proliferation and neointima formation in mice.
- Loss of GPR153 decreases inflammation and protects against neuroinflammation and stroke in mice.
- GPR153 controls cAMP levels, CREB phosphorylation, YAP/TAZ, and NF-κB activation in vascular cells.

## Abstract

Vascular cells express various G-protein-coupled receptors (GPCRs) with yet unknown function, among them orphan receptor GPR153. GPR153 was upregulated in smooth muscle cells (SMCs) in response to injury, and knockdown of GPR153 resulted in reduced proliferation and mildly altered differentiation in human SMCs. Mice with tamoxifen-inducible, SMC-specific GPR153 deficiency were partially protected against ligation-induced neointima formation, and their SMCs were characterized by reduced proliferation and dedifferentiation. Mechanistically, we show that GPR153 negatively regulates cellular cAMP levels, and thus the absence of GPR153 leads to an increase in CREB phosphorylation, reduced YAP/TAZ levels, and diminished NF-κB activation. Interestingly, a similar role of GPR153 was observed in endothelial cells (ECs), where loss of GPR153 resulted in reduced inflammatory gene expression and protected mice with EC-specific GPR153 deficiency in models of neuroinflammation and stroke. Taken together, orphan receptor GPR153 facilitates pro-inflammatory and pro-proliferative gene expression in ECs and SMCs by controlling cellular cAMP levels, thereby contributing to inflammation and vascular remodeling.

Vascular cells express various G-protein-coupled receptors (GPCRs) with yet unknown function, among them orphan receptor GPR153. GPR153 is upregulated in injured vessels, where it promotes smooth muscle proliferation and endothelial inflammation, and its inactivation protects mice in models of vascular diseases.

## Linked entities

- **Genes:** GPR153 (G protein-coupled receptor 153) [NCBI Gene 387509], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385]
- **Diseases:** neuroinflammation (MONDO:0004466), stroke (MONDO:0005098)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Gpr153 (G protein-coupled receptor 153) [NCBI Gene 100129] {aka 1110065N12Rik, PGR1}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 66826] {aka 5031411C02Rik, 9130012G04Rik, G4.5, Taz}
- **Diseases:** inflammation (MESH:D007249), neuroinflammation (MESH:D000090862), vascular damage (MESH:D057772), stroke (MESH:D020521)
- **Chemicals:** cAMP (-), tamoxifen (MESH:D013629)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12234975/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12234975/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12234975/full.md

---
Source: https://tomesphere.com/paper/PMC12234975